 | Up a level |
Liam, C.K. and Wahid, M.I.A. and Pathmanathan, R and Cheah, Y.K. and Ng, T.S.Y. (2013) Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients. Journal of Thoracic Oncology, 8 (6). pp. 766-772. ISSN 1556-0864,
Soo, Ross A. and Cho, Byoung Chul and Kim, Joo-Hang and Ahn, Myung-Ju and Lee, Ki Hyeong and Zimina, Anastasia and Orlov, Sergey and Bondarenko, Igor and Lee, Yun-Gyoo and Lim, Yueh Ni and Lee, Sung Sook and Lee, Kyung-Hee and Pang, Yong Kek and Fong, Chin Heng and Kang, Jin Hyoung and Lim, Chun Sen and Danchaivijitr, Pongwut and Kilickap, Saadettin and Yang, James Chih-Hsin and Arslan, Cagatay and Lee, Hana and Park, Seong Nam and Cicin, Irfan (2023) Central nervous system outcomes of lazertinib versus gefitinib in EGFR-mutated advanced NSCLC: A LASER301 subset analysis. Journal of Thoracic Oncology, 18 (12). pp. 1756-1766. ISSN 1556-0864, DOI https://doi.org/10.1016/j.jtho.2023.08.017.
Tan, Wan Ling and Chua, Kevin L. M. and Lin, Chia-Chi and Lee, Victor H. F. and Tho, Lye Mun and Chan, Anthony W. and Ho, Gwo Fuang and Reungwetwattana, Thanyanan and Yang, James C. and Kim, Dong-Wan and Soo, Ross A. and Ahn, Yong Chan and Onishi, Hiroshi and Ahn, Myung-Ju and Mok, Tony S. K. and Tan, Daniel S. W. and Yang, Fan (2020) Asian thoracic oncology research group expert consensus statement on optimal management of stage III NSCLC. Journal of Thoracic Oncology, 15 (3). pp. 324-343. ISSN 1556-0864, DOI https://doi.org/10.1016/j.jtho.2019.10.022.
